Non-specific bacterial cell membranes and inflammatory pathways

This target category encompasses broad structural components and physiological pathways rather than a single, defined molecular receptor. It primarily includes the bacterial cell membrane, which serves as a critical semi-permeable barrier and site for energy metabolism, and biofilms, which are complex multicellular communities encased in an extracellular polymeric substance (EPS) matrix (Donlan, 2002, PubMed: 12220291). Additionally, it covers inflammatory mediator pathways where therapeutic effects are achieved through non-specific modulation rather than targeted protein binding. Drugs interacting with these targets, such as polymyxins (e.g., Colistin) and lipopeptides (e.g., Daptomycin), typically employ mechanical or chemical mechanisms to disrupt structural integrity or alter electrochemical gradients (Zavascki et al., 2007, PubMed: 17303567). These targets are of high strategic interest for treating multi-drug resistant (MDR) Gram-negative infections and persistent biofilm-associated conditions like cystic fibrosis or chronic wounds. However, the lack of high specificity can lead to significant safety concerns, including nephrotoxicity and potential damage to host cell membranes (McDonnell & Russell, 1999, PubMed: 10030257).

Other names

Bacterial cell membraneBacterial biofilmNon-specific inflammatory pathwaysMicrobial lipid bilayerExtracellular polymeric substance (EPS)

Drugs targeting these structures typically act through physical or chemical disruption rather than specific lock-and-key receptor binding. For bacterial membranes, this involves pore formation, depolarization, or detergent-like lysis of the lipid bilayer (Zavascki et al., 2007, PubMed: 17303567). For biofilms, the mechanism involves the enzymatic or chemical degradation of the extracellular polymeric substance (EPS) matrix or the disruption of quorum sensing signals (Donlan, 2002, PubMed: 12220291). In inflammatory pathways without defined receptors, action may involve the non-specific neutralization of reactive oxygen species or the physical sequestration of pro-inflammatory molecules (McDonnell & Russell, 1999, PubMed: 10030257).